Recent Patents on Anti-Cancer Drug Discovery

Personal Subscription
Become EABM
Become Reviewer

Meet Our Editorial Board Member free to download

Volume:12   Issue: 3
Pp: 189-189
Andrew M. Chan
DOI: 10.2174/157489281203170905162628

Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents

Volume:12   Issue: 3
Pp: 190-207
Stephanie Lucas, Claire Soave, Ghazal Nabil, Zainab Sabry Othman Ahmed, Guohua Chen, Hossny Awad El-Banna, Q. Ping Dou* and Jian Wang*
DOI: 10.2174/1574892812666170619125503

Poly (ADP-Ribosyl) Polymerase 1 Inhibitors: A Patent Review

Volume:12   Issue: 3
Pp: 208-220
Mengda Cao, Xi Sun, Yanjun Zhou, Wen Huang, Ling Meng* and Ji-Fu Wei*
DOI: 10.2174/1574892812666170508124932

Immune Cells Act as Promising Targets for the Treatment of Bone Metastasis

Volume:12   Issue: 3
Pp: 221-233
Guojing Luo, Yuedong He, Qian Zhao and Xijie Yu*
DOI: 10.2174/1574892812666170606123113

Epithelial Mesenchymal Transition in Cancer Progression: Prev entive Phytochemicals

Volume:12   Issue: 3
Pp: 234-246
Soorya P. Illam, Arunaksharan Narayanankutty, Shaji E. Mathew , Remya Valsalakumari , Rosemol M. Jacob and Achuthan C. Raghavamenon*
DOI: 10.2174/1574892812666170424150407

Role of FoxM1 in the Progression and Epithelial to Mesenchymal Transition of Gastrointestinal Cancer

Volume:12   Issue: 3
Pp: 247-259
Jing Zhang, Yangyang Niu and Chen Huang*
DOI: 10.2174/1574892812666170424144352

Indication of Bevacizumab for Cerebral Radiation Necrosis

Volume:12   Issue: 3
Pp: 272-277
Hongqing Zhuang*, Xiangkun Yuan, Zhiyong Yuan * and Ping Wang
DOI: 10.2174/1574892812666170425124430

Patent Selections promotion: free to download

Volume:12   Issue: 3
Pp: 278-279

DOI: 10.2174/157489281203170905172134